Krishna Institute of Medical Sciences Ltd. Results Earnings Call for Q1FY24
Conference Call with Krishna Institute of Medical Sciences Management and Analysts on Q1FY24 Performance and Outlook. Listen to the full earnings transcript.08-08-2023
08-08-2023
KIMS declines despite a profitable Q1
Hyderabad-based Krishna Institute of Medical Sciences reported a 15.5 percent YoY rise in Q1 consolidated profit to Rs 80.8 crore driven by a healthy topline.08-08-2023
Q1FY24 Quarterly Result Announced for Krishna Institute of Medical Sciences Ltd.
Healthcare Facilities company Krishna Institute of Medical Sciences announced Q1FY24 results: Gross revenue at Rs 609 crore, a growth of 21.6% on a YoY and 4.9% on a QoQ basis. Operating EBITDA of Rs 160 crore, an increase of 12.4% YoY and a decrease of 4.7% QoQ basis. EBITDA margin at 26.3% vs. 28.5% in Q1FY23 and 28.9% in Q4FY23. PAT at Rs 87 crore in Q1FY24 against Rs 79 crore and Rs 99 crore in Q1FY23 and Q4FY23 respectively. Conducted 3.83 lakh OPD consults in Q1FY24, up by 18% and 0.4% YoY and QoQ basis. Bed occupancy in Q1FY24 at 70.4%, up by 5% on YoY and down by 0.4% on QoQ basis. ARPOB increased to Rs 31,697 in Q1FY24 showing 5.0% growth YoY and 3.7% growth QoQ basis. Cash and Cash Equivalents at Rs 178 crore in Q1FY24. Net Debt to Equity ratio at 0.22. Announcing Q1FY24 results, Dr. B Bhaskar Rao, CMD, KIMS Hospitals, said, “The first quarter of FY24 has started on a robust note with all engines performing optimally. Despite it being a seasonally lean quarter, we have done reasonably well on key parameters. I am particularly happy to note that the integration efforts of our recently acquired assets have started seeing fruition. We continue to focus on two critical parameters: Clinical Excellence and Affordable Quality Care. I am optimistic that we are on track to meet our targets for FY24”. Result PDF07-08-2023
Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release for the Quarter ended 30th June, 2023.07-08-2023
Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation for the quarter ended 30th June, 2023.07-08-2023
Krishna Institute of Medical Sciences Ltd - 543308 - Outcome Of Board Meeting Held On 07Th August 2023 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
1. Approval of unaudited financial Results for the Quarter ended 30.06.2023. 2. Dr. B Bhaskara Rao has intimated the Board that he has acquired 64.36% of Equity stake in Som Datt Finance Corporation Limited and has been inducted into its Board as Director.07-08-2023
Krishna Institute of Medical Sciences Ltd - 543308 - Board Meeting Outcome for Outcome Of Board Meeting Held On 07Th August 2023 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Further to our intimations dated 31st July 2023, the Board of Directors, at its meeting held today, has approved the Un-Audited (Standalone and Consolidated) Financial Results of the Company for the 01st Quarter ended 30th June 2023 together with Limited Review Reports which has been reviewed by the Audit Committee and approved by the Board of Directors. Dr. B. Bhaskara Rao, Promoter & CMD has intimated to the Board that he has acquired 64.36% of the equity stake in M/s. Som Datt Finance Corporation Ltd, (Listed NBFC) and has been inducted into its Board as a Director.07-08-2023
Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached copies of newspaper advertisement cutting of the Notice of Shareholders intimating the details of the 21st Annual General Meeting06-08-2023
Krishna Institute of Medical Sciences Ltd - 543308 - Business Responsibility and Sustainability Reporting (BRSR)
BRSR Report 2022-2305-08-2023
Krishna Institute of Medical Sciences Ltd - 543308 - Reg. 34 (1) Annual Report.
Pursuant to the provisions of Regulation 34(1) of the Listing Regulations, please find attached a copy of the Notice convening the 21st Annual General Meeting of the Company, scheduled to be held on Wednesday, August 2023 at 4.00 PM IST through Video Conferencing/ Other Audio Visual Means ('VC/ OAVM').05-08-2023